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Abstract 
Rationale: For intravascular stent implantation to be successful, the processes of vascular tissue repair and 
therapy are considered to be critical. However, the mechanisms underlying the eventual fate of vascular 
smooth muscle cells (VSMCs) during vascular tissue repair remains elusive. In this study, we hypothesized that 
M2 macrophage-derived exosomes to mediate cell-to-cell crosstalk and induce dedifferentiation phenotypes in 
VSMCs. 
Methods: In vivo, 316L bare metal stents (BMS) were implanted from the left iliac artery into the abdominal 
aorta of 12-week-old male Sprague-Dawley (SD) rats for 7 and 28 days. Hematoxylin and eosin (HE) were used 
to stain the neointimal lesions. En-face immunofluorescence staining of smooth muscle 22 alpha (SM22α) and 
CD68 showed the rat aorta smooth muscle cells (RASMCs) and macrophages. Immunohistochemical staining 
of total galactose-specific lectin 3 (MAC-2) and total chitinase 3-like 3 (YM-1) showed the total macrophages 
and M2 macrophages. In vitro, exosomes derived from IL-4+IL-13-treated macrophages (M2Es) were isolated by 
ultracentrifugation and characterized based on their specific morphology. Ki-67 staining was conducted to 
assess the effects of the M2Es on the proliferation of RASMCs. An atomic force microscope (AFM) was used to 
detect the stiffness of the VSMCs. GW4869 was used to inhibit exosome release. RNA-seq was performed to 
determine the mRNA profiles of the RASMCs and M2Es-treated RASMCs. Quantitative real-time PCR 
(qRT-PCR) analysis was conducted to detect the expression levels of the mRNAs. Western blotting was used 
to detect the candidate protein expression levels. T-5224 was used to inhibit the DNA binding activity of AP-1 
in RASMCs. 
Results: M2Es promote c-KIT expression and softening of nearby VSMCs, hence accelerating the vascular 
tissue repair process. VSMCs co-cultured in vitro with M2 macrophages presented an increased capacity for 
de-differentiation and softening, which was exosome dependent. In addition, the isolated M2Es helped to 
promote VSMC dedifferentiation and softening. Furthermore, the M2Es enhanced vascular tissue repair 
potency by upregulation of VSMCs c-KIT expression via activation of the c-Jun/activator protein 1 (AP-1) 
signaling pathway. 
Conclusions: The findings of this study emphasize the prominent role of M2Es during VSMC dedifferentiation 
and vascular tissue repair via activation of the c-Jun/AP-1 signaling pathway, which has a profound impact on the 
therapeutic strategies of coronary stenting techniques. 
Key words: M2 macrophage, exosomes, stiffness, vascular smooth muscle cell, dedifferentiation, intravascular 
stent 
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Introduction 
Coronary stenting has almost universally 
superseded the use of balloon angioplasty alone for 
the percutaneous treatment of coronary disease [1]. 
However, vascular injury caused by stent 
implantation always leads to restenosis because of the 
uncontrollable proliferation of vascular smooth 
muscle cells (VSMCs) [2]. The proliferation of VSMCs 
in the vascular injury area can be caused by many 
factors, but crucial among them is the stimulation of 
infiltrated macrophages [3,4]. Macrophages, including 
M1 and M2 macrophages, participate in the repair of 
vascular injury after stent implantation [5,6]. 
However, the mechanism underlying the effects of 
macrophages on the fate regulation of VSMCs during 
vascular tissue repair and therapy remains elusive. 
Recently, extracellular vesicles (EVs) have been 
considered an orchestrator between different kinds of 
cells, in local or distant microenvironments and 
within multiple pathophysiological processes. For 
example, EVs from macrophage foam cells can 
promote VSMC migration and adhesion, which might 
be mediated by the integration of EVs into VSMCs [4]. 
Exosomes from nicotine-treated macrophages 
accelerate the development of atherosclerosis by 
increasing VSMC migration and proliferation through 
its target PTEN [7]. Exosomes derived from M1 
macrophages have been shown to aggravate 
neointimal hyperplasia by delivering miR-222 into 
VSMCs [8]. Nonetheless, there is still no definitive 
conclusion as to whether or how M2 macrophage 
exosomes affect the behavior of VSMCs during 
vascular tissue repair after stent implantation. 
On the other hand, VSMCs may exhibit stem cell 
properties, including the expression of stem cell 
markers (such as c-KIT) [9], softness [10], and high 
proliferation in response to inflammation or other 
microenvironmental factors in the vascular injury site. 
Stem cell marker expression by VSMCs occurs in the 
early injury phases, which probably plays a major role 
in vascular remodeling [11,12]. Although it is well 
accepted that c-KIT+ VSMCs can modulate vascular 
remodeling, the detailed mechanisms by which 
inflammatory cells regulate VSMC functions and the 
related mechanism remain unclear. 
The objective of this work was to explore the 
mechanism of cell conversion in the stented area, as 
well as to understand the significance of conversion to 
neointimal formation. This work shows that most of 
the c-KIT+ VSMCs around the stent struts originate 
from the medial VSMCs. M2 macrophage exosomes 
(M2Es) specifically regulate VSMC dedifferentiation 
by activating c-Jun/activator protein 1 (AP-1) around 
the stent struts, enhancing the vascular repair 
potency. 
Methods 
Stent implantation in rat aortas 
The detailed methods are available in the Online 
Appendix. In brief, 12-week-old male Sprague- 
Dawley (SD) rats were pre-dosed orally with aspirin 
and clopidogrel 3 days before surgery, and they were 
maintained on this dual antiplatelet therapy 
throughout the study to reduce the risk of in-stent 
thrombosis. Vascular access was obtained by left 
femoral artery cutdown and the insertion of a 
homemade sheath. A stainless steel stent (8-cell, 2.5 
mm × 0.8 mm; Amsino Medical, Beijing, China) was 
pre-mounted on VasoTech® Miniature balloon 
catheters (15 mm × 1.5 mm, VasoTech, Inc.) and 
deployed (10 ATM for 30 s, 3 times) into the 
abdominal aortic. The rats were allowed to recover in 
heated chambers for 24 h and were then returned to 
normal housing conditions, where they were 
maintained on aspirin + clopidogrel-supplemented 
food for another 7 or 28 days before being sacrificed. 
To deliver the M2Es into the stented abdominal 
aorta and to avoid any potential systemic side effects, 
we applied an established local delivery model via the 
pluronic gel F-127, as described in previous reports 
with minor modification [13,14]. Briefly, immediately 
after stent implantation, 50 µg M2Es in phosphate 
buffer saline (PBS) preloaded into 50 µL 20% pluronic 
gel F-127 (Sigma) at 4 °C was applied locally to the 
adventitia around the injured artery segments. Then, 
M2Es (10 µg) in PBS or vehicle (PBS) were injected 
into the tail intravenously every three days until the 
rats were sacrificed. 
Electrolysis 
Following fixation in 4% PFA, the stented 
murine arteries were immersed in 5% (w/v) citric 
saline, and electrochemical dissolution was 
performed by passing a small direct current through 
the stent as described previously [15]. 
H&E staining 
Hematoxylin and eosin (H&E) staining was 
performed after the rats were euthanized and the 
stents were electrolyzed. Artery samples were fixed in 
4% PFA for 24 h, and then paraffin-embedded. They 
were sectioned (5 µm sections) and stained with H&E. 
An optical microscope (Leica, DMI6000B, Germany) 
was used to analyze these slides. 
Cell culture 
A line of rat VSMCs (A7R5, ATCC) was cultured 
in high-glucose Dulbecco's modified Eagle medium 
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(DMEM, Gibco) with 10% fetal bovine serum (FBS, 
Gibco). THP-1 human acute monocytic leukemia cells 
were kindly provided by the Stem Cell Bank, Chinese 
Academy of Sciences. Cells were cultured in 
RPMI-1640 containing 10% FBS (Gibco BRL). Cells 
were maintained at 37 °C in a 5% CO2 humidified 
environment. To mimic a pro-inflammatory 
environment and consequently promote M1 or M2 
polarization, the M1 cells were stimulated with 
lipopolysaccharide (LPS) and interferon-γ (IFN-γ). 
For M2 polarization, the cells were stimulated with 
interleukin-4 (IL-4) and interleukin-13 (IL-13) were 
added back with DMSO (carrier) for 48 h [16]. 
Rat aorta smooth muscle cells (RASMCs) were 
isolated from the thoracic aorta of male SD rats (200–
250 g body weight) using the explant technique. Cells 
were cultured in DMEM supplemented with 20% FBS 
and 1% penicillin/streptomycin and incubated in 5% 
CO2 at 37 °C. Primary RASMCs from passages 5 to 12 
at 80% confluence were used for the experiments. The 
cells were serum-starved (5 mM glucose with 0.2% 
bovine serum albumin (BSA)) for 24 h before use in 
the experiments. T-5224 (10 µM, HY-12270, MCE) was 
used to inhibit the DNA binding activity of AP-1 in 
the RASMCs. 
Exosome purification and characterization 
For M2 macrophage exosome isolation, the cells 
were incubated with 10µM DID (1,1’-dioctadecyl- 
3,3,3‘,3’-tetramethylindodicarbocyanine perchlorate) 
for 20 min, and afterwards washed 3 times with PBS 
for 5 min each time. Then, the cells were cultured in 
exosome depleted medium for 48 h before 
supernatant collection. The extracellular medium was 
concentrated using a Centricon Plus-70 centrifugal 
filter. Debris and dead cells in the medium were 
removed by centrifugation at 1000 × g for 10 min at 4 
°C, and subsequently the supernatants were 
transferred to a fresh tube and centrifuged at 10,000 g 
for 30 min at 4 °C. The medium was then subjected to 
ultracentrifugation at 100,000 g for 70 min at 4 °C. 
After washing with PBS (100,000 g for 70 min), the 
exosome containing pellet was re-suspended in PBS. 
Nanoparticle Tracking Analysis (NTA) particle size 
characterization of the exosomes was carried out by 
NanoSight analysis (Malvern Instruments). 
RNA-seq and Real-time RT-PCR 
The quality of the RNA for sequencing was 
determined using a Bioptic Qsep100 Bioanalyzer. 
Library preparation used the KAPA RNA-Seq Library 
Preparation Kit (KAPA Biosystems Cat#07960140001) 
and the RNAs were single-end sequenced on Illumina 
HiSeq 3000 machines. The reads were aligned using 
HISAT2 with the default parameters for the rat 
genome. Transcript assembly and differential 
expression were determined using Cufflinks with 
Refseq mRNAs to guide assembly. RNA-seq data 
were analyzed using the cummeRbund package in R. 
The heatmap was generated with Heatmap Builder. 
Gene set enrichment analysis was performed using 
the GSEA app (Broad Institute) based on the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) gene 
lists. 
Briefly, RNAs from VSMCs were isolated with 
an RNA isolation kit (Takara, Inc.). qRT-PCR for 
SM22α, α-SMA, c-Kit, Oct-4, Klf4, Nanog, c-Myc, Sox2, 
Kitlg, Map2k1, Fosl1, Opn, Elastin, Mgp, Jun and Sca-1 
was performed on cDNA generated from 1000 ng of 
total RNA using the protocol of the qRT-PCR mRNA 
Detection Kit (Takara). Amplification and detection of 
the specific products were performed with a Roche 
Lightcycler 480 Detection System. As an internal 
control, Gapdh was used for the other template 
normalizations. Fluorescent signals were normalized 
to an internal reference, and the threshold cycle (Ct) 
was set within the exponential phase of the PCR. The 
relative gene expression was calculated by comparing 
cycle times for each PCR target. The target PCR Ct 
values were normalized by subtracting the Gapdh Ct 
value, which generated the ΔCt value. The relative 
expression level between treatments was then 
calculated using the following equation: relative gene 
expression = 2 −(ΔCtsample−ΔCtcontrol). 
Western blotting 
The method used was similar to that described 
previously [16]. Cells were harvested and washed 
with cold PBS and then re-suspended in lysis buffer 
(Beyotime, China) supplemented with protease 
inhibitors (Roche). The protein concentration was 
determined using the Bio-Rad Protein Assay Reagent 
and 50 µg of whole lysate was applied to 
SDS-polyacrylamide gel electrophoresis (PAGE). 
They were transferred to Hybond polyvinylidene 
fluoride (PVDF) membranes (Millipore Immobilon-P), 
followed by standard western blot procedures. After 
blocking with 5% skimmed milk powder in 
Tris-buffered saline Tween-20 (TBST), the membranes 
were incubated with each of the following antibodies 
at 4 °C for 18 h: SM22α (Abcam, #ab14106), α-SMA 
(Abcam, #ab21027), c-KIT (Santa Cruz, #sc-365504) 
and GAPDH (CST, #5174). The bound primary 
antibodies were detected by the use of an HRP- 
conjugated secondary antibody and an ECL detection 
system (CST). The band density was semiquantified 
by ImageJ2x. 
AFM 
For Atomic Force Microscope (AFM) 
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characterization of the cells, a Nanowizard II AFM 
(JPK Instruments AG, Berlin, Germany), as described 
previously, was used. For a control group, VSMC 
were cultured in serum-free DMEM for 24 h. We 
divided the experimental group into three subgroups, 
RASMC treated with M2 Macrophage supernatant, 
RASMC co-cultured with M2 macrophages in a 
Transwell (membrane pore =0.4 µm) plate and 
RASMC treated with M2Es for 24 h, respectively. 
Imaging of the washed VSMC was done in contact 
mode in air and under PBS with silicon and V-shaped 
silicon nitride probes (SICON-Applied Nano-
structures and PNP-TR-Nanoword). The resultant 
spring constant was evaluated as 0.01 N m-1. Force 
spectroscopy on the living cells was conducted with 
V-shaped soft silicon nitride probes (MLCT. Bruker). 
The force curves were analyzed by Atomic J to 
calculate the sample Young's modulus using the 
Hertz model [17]. AFM image processing of the 
samples was done using the JPK data processing 
software (v.4.4.29). Each group analyzed at least ten 
cells, and for each cell at least twenty points were 
measured. The stiffness of each cell was calculated 
from the average stiffness of all of the effective points 
on each cell. 
TEM 
For transmission electron microscopy (TEM), 
exosomes were fixed with 2.5% glutaraldehyde and 
loaded on formvar and carbon-coated copper grids. 
The grids were placed on 2% gelatin at 37 °C for 20 
min, rinsed with 0.15 M glycine/PBS, and the sections 
were blocked using 1% cold water fish-skin gelatin. 
Grids were viewed using a JEOL 1200EX II (JEOL) 
transmission electron microscope and photographed 
using a Gatan digital camera (Gatan). 
Co-culture assay 
After transfection with DII (1,1-dioctadecyl- 
3,3,3,3-tetramethylindocarbocyanine iodide) (10 µM) 
for 20 min, they were washed 3 times with PBS for 5 
min each time. Macrophages (0.1-3×105/well) were 
co-cultured with A7R5 cells (incubated with 10 µM 
DIO (3,3′-dioctadecyloxacarbocyanine perchlorate)) or 
RASMCs at a ratio of 1:1 using a Transwell plate (0.4 
µm polycarbonate filter, Corning) for 24 h, with A7R5 
cells or RASMCs placed in the lower chamber and 
macrophages in the upper chamber. After washing 
with PBS three times, the appearance of DII red 
fluorescence on the A7R5 or RASMCs was examined. 
GW4869 (Sigma-Aldrich, 10 µM) was added to block 
exosome secretion. 
Immunofluorescence staining 
In brief, vessels were fixed in 4% para-
formaldehyde. Rat stented aortas were electrolyzed to 
remove the stents, as described above, dehydrated in 
graded ethanol, cleared in Histo-Clear and embedded 
in paraffin wax, before sectioning and subsequent 
staining. Serial paraffin sections were dewaxed and 
rehydrated. Tissue sections were subjected to citric 
acid antigen retrieval, and endogenous peroxidase 
activity was inhibited by incubation with 3% 
hydrogen peroxide. Sections were incubated with 
CD68 antibody (Abcam, ab955, 1:200), c-KIT antibody 
(Santa Cruz, sc-365504, 1:100) or SM22α antibody 
(Abcam, ab14106, 1:200) overnight at 4 °C after 
blocking with 1% donkey or goat serum, followed by 
incubating with secondary antibody at room 
temperature for 1 h away from the light. Images were 
observed with a laser scanning confocal microscope 
(Lecia, SP8, Germany). 
For cell immunofluorescence, cells were washed 
three times with PBS for 3 min, then perfused with 4% 
PFA. Fixed cells were permeabilized with 0.2% Triton 
X-100 in PBS for 10 min. After washing with PBS and 
blocking with 1% BSA for 1 h, the cells were incubated 
with antibodies against c-KIT at 4 µg/ml (Santa Cruz, 
sc-365504) or SM22α (Abcam, ab14106) at 5 µg/ml 
overnight under 4 °C. The corresponding fluorescent- 
labeled secondary antibody was added for 1h. 
Following re-staining with DAPI, the cells were 
observed with a laser confocal scanning microscope. 
En-face immunofluorescence staining 
For en-face confocal laser scanning microscopy 
[18], the rats were perfused with 4% PFA in a HEPES 
buffer. Stented vessels were isolated and 
permeabilized with 0.2% Triton X-100 in PBS. 
Permeabilization and all of the following staining 
steps were performed in Eppendorf tubes. After 
rinsing with PBS-BSA (0.2% BSA in PBS) and 
immersion for 30 min in blocking solution (0.2% BSA 
and 5% goat serum in PBS or 12.5 mg purified goat 
IgG/mL), the tissue samples were incubated for 1 to 2 
h in a PBS-BSA solution containing the primary 
antibody. In the single whole-mount staining 
experiments, primary monoclonal antibodies were 
used to detect the expression of c-KIT (Santa Cruz, 
sc-365504), or CD68 (Abcam, ab955). For single 
immunofluorescence labeling, donkey anti-mouse 
coupled to DTAF (dilution, 1/100, Jackson 
Laboratories) was used as the secondary antibody. 
After double staining with DAPI, the stented vessels 
were observed with a confocal laser scanning 
microscope. 
Immunohistochemical staining 
Four-micron-thick plaque sample sections were 
incubated with a Total galactose-specific lectin 3 
(MAC-2) antibody (Abcam, ab2785, 1:100), total 
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chitinase 3-like 3 (YM-1) antibody (Abcam, ab192029, 
1:500), AP-1 antibody (Abcam, ab40766, 1:100) or the 
proliferating cell nuclear antigen (PCNA) antibody 
(Abcam, ab29, 1:100) overnight at 4 °C after blocking 
with 1% goat serum. Slides underwent color 
development with DAB and hematoxylin 
counterstaining. Images were obtained with an optical 
microscope (Leica DMI6000B). 
Statistical analyses 
Quantitative data were expressed as mean ± 
SEM. N indicates the number of independent 
experiments. Visual assessment was used to check for 
any lack of normality; because there was no evidence 
of this, one-way analysis of variance (ANOVA) 
followed by Tukey multiple comparison tests (for 
comparisons of >2 groups) or Student's t-test (for 
comparisons of 2 groups) were conducted. All 
statistical analyses were conducted using Prism 
version 4 (GraphPad Software, San Diego, California). 
For the qRT-PCR experiments, values are expressed as 
fold change. All statistical analyses used Graph Pad 
Prism v4 (GraphPad Software ®). 
Results 
M2 macrophages are adjacent to c-KIT+ 
VSMCs after intravascular stent implantation 
316L bare metal stents (BMS) were implanted 
from the left iliac artery into the abdominal aorta of 
SD rats to identify the existence and localization of 
c-KIT+ VSMCs in the stent implantation sites. 
Immunofluorescence images showed that a large 
number of SM22α+ cells expressed c-KIT in the 
neointima at 7 days post-stenting. In comparison, at 
day 28 post-stenting, few c-KIT-+ SM22α+ cells were 
found surrounding the stent struts, while large 
numbers of c-KIT and SM22α double-positive cells 
were found around the stent wire in the neointima 
(Figure S1A). Strikingly, c-KIT and SM22α 
double-positive cells among the SM22α+ cells in the 
intima increased significantly from 13.64 ± 0.70% to 
63.78 ± 4.12% at 7 and 28 days post-stenting, 
respectively (Figure S1B). 
To analyze the relationship between the repaired 
regions and c-KIT+ cells, we detected the c-KIT+ cells 
from the proximal to the distal parts of the stented 
vessels (Figure 1A). Through en-face staining, 6.14% of 
the c-KIT+ cells were found surrounding stent struts 
located in the distal part of the stented vessels 
(Figures 1B and 1D) compared with less than 1% and 
only 1.79% of c-KIT+ cells in the proximal and middle 
part of the stented vessels, respectively. 
En-face staining of CD68 in the stented 
abdominal aortas was conducted to further study 
whether the macrophages were synchronized in 
appearance and localization with the c-KIT+ VSMCs. 
CD68+ cells were also found in the distal part of the 
stent implanted segments at 7 days post-stenting, 
while there were fewer CD68 positive cells in the 
normal abdominal aorta (Figure 1C). Almost 60 CD68 
positive cells/mm2 were found in the distal part of the 
stent implanted vessels (Figure 1E). MAC-2 (marker 
for total macrophage) and YM-1 (marker for M2 
macrophage) were detected in the distal part of the 
stented vessels by immunohistochemistry in order to 
further explore the macrophage type in the stented 
vessels. Both MAC-2+ cells and YM-1+ cells were 
found around the stent struts in the neointima. YM-1+ 
cells infiltrated deeper into the developing neointima 
and adjacent to the VSMCs at both 7 and 28 days 
post-stenting (Figures S2A and S2B). MAC-2+ cells 
were 8.77 ± 0.64% and 2.23 ± 0.20% in the developing 
neointima at 7 and 28 days post-stenting, respectively. 
The YM-1+ cells were 7.32 ± 0.45% and 1.43 ± 0.14% in 
the developing neointima at 7 and 28 days 
post-stenting, respectively (Figure S2C). These 
findings suggest that M2 macrophages may be a 
critical regulator in the c-KIT+ cells post-stent 
pathophysiological response to injury. 
Macrophages communicate with VSMCs 
through EVs 
Next, we established a Transwell co-culture 
system to explore whether macrophages could 
enhance progenitor formation of VSMCs (Figure 2A). 
Naive macrophages (M0), LPS + IFN-γ stimulated 
macrophages (M1) and IL-4 + IL-13 stimulated 
macrophages (M2) stained with fluorescent dyes (red 
DII for the lipid membranes) were co-cultured with 
A7R5 stained with DIO in a Transwell (membrane 
pore = 0.4 µm) plate for 24 h. The morphology of the 
A7R5 cells was transformed from a long spindle to a 
polygon after co-culture with all kinds of 
macrophages (Figure S4). 
The appearance of red fluorescent DII dyes in the 
A7R5 VSMCs demonstrated that the DII-stained 
membrane was delivered from the macrophages in 
the upper chamber of the Transwell to the recipient 
VSMCs seeded in the lower well. Compared with the 
M0 and M1 macrophage EVs, the VSMCs tended to 
uptake more of the EVs from the M2 macrophages 
(Figures S5 and S6). However, only RASMCs 
co-cultured with M2 macrophages showed an 
apparent aggregation of DII-stained cell membranes 
(Figure 2B). XZ and YZ views of the A7R5 confirmed 
that EVs from M2 macrophages were incorporated 
into the cells (Figure 2C). 
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Figure 1. Both c-KIT+ and CD68+ cells were present in the distal part of the stented rat abdominal aorta vessels. (A) Schematic diagram of abdominal aortic stent implantation 
in rats; (B) 1 week after 316L BMS implantation, c-KIT+ cells were found at the DP of the stent segment compared to the NC, MP and PP. Areas under enhanced magnification 
correspond to the regions highlighted by the hatched rectangles. Scale bar: 100 µm (Merge); Scale bar:10 µm (Enlarged). (C) A week after implantation of the 316L BMS, the 
proportion of CD68+ cells in three positions of the stent segment were counted. The white arrow indicates the CD68+ cells. Scale bar: 100 µm (Merge) Scale bar: 10 µm 
(Enlarged). (D) Quantification of c-KIT+ cells in the three given fields of view per group. The results are representative of three independent experiments. (E) Quantification of 
CD68+ cells from three fields of view per group. N = 6 for each point in each group. Error bars are Mean ± SEM. *** P < 0.001 by one-way, ANOVA, ns means no difference. Full 
length of DP, MP, and PP. Abbreviations: NC, No-stented rat abdominal aorta vessels; DP, Distal Part of stented rat abdominal aorta vessels; MP, middle part of stented rat 
abdominal aorta vessels; PP, proximal part of stented rat abdominal aorta vessels. 
 
Figure 2. Microvesicles secreted by M2 macrophages can be incorporated into VSMCs. (A) Schematic diagram of co-culture of macrophages and VSMCs. (B) Naive (M0) 
macrophages, LPS+IFN-γ-stimulated (M1) macrophages and IL-4+IL-13-stimulated (M2) macrophages incubated with DII were co-cultured with A7R5 incubated with DIO in a 
Transwell (membrane pore = 0.4 µm) plate for 24 h. The white arrow indicates where DII accumulates in the VSMCs. Scale bar: 100 µm. (C) XZ and YZ side views of the A7R5 
(green) co-cultured with M2 macrophage (red). Scale bar: 100 µm. 
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Figure 3. M2 macrophage EVs upregulate the expression of c-KIT of SMCs, broke up the F-actin skeleton of SMCs and decreased their stiffness. (A) Co-localization of c-KIT and 
macrophage microvesicle in RASMC, scale bar: 10 µm. (B) XZ and YZ sides view of the c-KIT (green) co-cultured with M2 macrophages (red), scale bar: 10 µm. (C) 
FITC-phalloidin dyeing of RASMC. 5 µg/ml FITC-phalloidin detects RASMCs' F-actin after 24 h of M0, M1 and M2 macrophage transwell co-culture stimulation, scale bar: 10 µm. 
(D) Representative force curves of force upon approach between the sphere and RASMC. Supernatant: RASMC treated with M2 macrophage supernatant; Transwell: RASMC 
co-cultured with M2 macrophages in a Transwell plate. (E) Quantification of resistance to mechanical deformation (stiffness) of the cells as in B for an applied load of 30 nN. At 
least ten cells were analyzed for each condition. Error bars represent Mean ± SEM. P values indicate the statistical significance of the differences of treatments versus the relevant 
control. **** P < 0.0001 by one-way, repeated-measures ANOVA (for 3 groups). 
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M2 macrophages upregulate the expression of 
c-KIT and decrease the cellular stiffness of 
VSMCs 
After detecting the stem cell marker c-KIT with 
immunostaining, the c-KIT of the inferior ventricular 
VSMCs was found to be upregulated in the co- 
cultured model (Figure 3A). Moreover, we analyzed 
the c-KIT, α-SMA and SM-22α protein levels after 
VSMC co-culturing with macrophages by western 
blotting. The data showed upregulated expression of 
c-KIT in RASMCs co-cultured with M2 macrophages 
but downregulated expression levels of α-SMA and 
SM-22α (Figure S7). Furthermore, compared with the 
M0 and M1 macrophage EVs treated group, 
FITC-phalloidin dyes of the RASMCs showed that the 
VSMCs that absorbed DII-stained M2 macrophages 
EVs had F-actin skeleton depolymerization (Figure 
3C). 
Stiffness changes can indirectly reflect the 
de-differentiation of VSMCs. We used colloidal probe 
force mode AFM to elucidate whether macrophages 
can regulate the stiffness of VSMCs. First, RASMCs 
were stimulated with macrophage conditioned 
medium (M2 macrophages supernatant: DMEM = 1:9) 
or by Transwell co-culture. Force curves of force upon 
approach between the sphere and an RASMC showed 
that the RASMC had a force curve with a lower slope 
under the M2 macrophage stimulation (Figure 3D). 
The JPK software analysis showed that the stiffness of 
the RASMCs was reduced significantly after the 
conditional medium stimulation or co-culture with 
M2 macrophages (Figure 3E). 
Then, we pre-treated THP-1 macrophages with 
10 µM GW4869, an inhibitor of exosome biogenesis/ 
release, followed by IL-4 + IL-13 stimulation. We 
found that c-KIT expression of VSMCs co-cultured 
with M2 macrophages was not upregulated after 
GW4869 inhibited exosomes secretion by the 
macrophages (Figure S8A). At the mRNA level, the 
expression of c-Kit, SM22α, and α-SMA was restored to 
control levels after exosome inhibition (Figure S8B). 
These experiments showed that exosomes derived 
from M2 macrophages were responsible for the 
upregulation of c-KIT expression of the VSMCs after 
M2 macrophage stimulation. 
Exosomes secreted by M2 macrophages 
promote VSMCs softening and 
dedifferentiation 
TEM (Figure 4A) and NTA (Figure 4C) showed 
that the diameter of the exosomes extracted from the 
M2 macrophages supernatant was approximately 100 
nm. To confirm that VSMCs directly engulf exosomes, 
exosomes labeled with 17 nm gold nanoparticles were 
incubated with the RASMCs for 12 h. The 17 nm gold 
nanoparticle labeled exosomes were engulfed by the 
VSMCs and could be detected by TEM (Figure 4B). In 
vitro, VSMCs absorbed more DID-dyed M2Es with the 
progression of time. At the same time, F-actin 
filaments of the VSMCs were depolymerized and 
rearranged (Figure 4D). 3D images of the M2Es- 
internalized VSMCs after 24 h treatment showed that 
depolymerization of F-actin took place around the 
DID-dyed M2Es (Figure 4E). The largest amount of 
DID-dyed M2Es was absorbed after 24 h based on the 
time serial statistical results (Figure 4F). 
VSMCs were co-cultured with purified M2Es to 
clarify whether the M2Es induced progenitor 
strengthening and stiffness changes in the VSMCs. 
Compared with the control group, RASMCs co- 
cultured with M2Es were significantly softer than 
normal RASMCs. Young's modulus of untreated 
RASMCs and M2Es treated RASMCs were 1308 ± 
49.94 Pa and 232.3 ± 14.76 Pa, respectively (Figures 5A 
and 5B). The VSMCs also developed a spherical 
morphology after exposure to M2Es. The ratio of long 
axis to short axis decreased from 5.620 ± 0.3676 to 
2.161 ± 0.1652 (Figure S9). FITC-phalloidin staining 
showed that the F-actin skeleton of P3-RASMCs was 
broken after M2E treatment (Figure 5C). 
Next, we hypothesized that M2Es could cause 
VSMC dedifferentiation at the protein level. After 
treatment with M2Es for 24 h, VSMC had a high level 
of c-KIT expression. Furthermore, the filamentous 
structure of SM22α in the VSMCs was no longer 
present under M2Es treatment (Figure 5D). We also 
examined the levels of c-KIT, SM22α and α-SMA 
proteins in untreated RASMCs and in M2Es 
stimulated RASMCs by western blotting. The results 
showed that c-KIT was highly upregulated in the 
M2Es stimulated group. SM22α and α-SMA were 
downregulated in the M2Es stimulated group (Figure 
5E and 5F). The expression of SM22α and α-SMA were 
significantly reduced in the RASMCs after M2Es 
stimulation or co-culture with M2 macrophages, 
while the stem cell marker c-Kit was significantly 
increased. The other two markers Sca-1 and Oct-4 
were not detected (Figure 5G). These data strongly 
indicate that M2Es are critical for the dedifferentiation 
of RASMCs. 
Exosomes secreted by M2 macrophages 
promote vascular therapy 
We hypothesized that M2Es could enhance the 
vascular repair potency of VSMCs after abdominal 
aortic stent implantation in a rat model. 
Morphometric analysis found that M2Es-treated stent 
vessels had an increased neointimal area compared 
with PBS-treated controls at 7 days and 28 days (0.039 
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± 0.006 vs. 0.065 ± 0.006, P < 0.01, day 7; 0.11 ± 0.009 vs. 
0.17 ± 0.025, P < 0.05, day 28), but neointimal 
thickness, and the neointima-to-medial ratio did not 
differ significantly at 7 days and 28 days (Figures 6A 
and 6B, Table S2). A significant increment in percent 
stenosis in the M2Es-treated stent vessels compared 
with PBS-treated controls was also observed at 7 days 
(Figures 6C and 6D, Table S2). Furthermore, the total 
vessel area and medial area did not differ significantly 
at 7 days and 28 days (Figure 6E, Table S2). 
M2Es-treated stented rats contained greater numbers 
of MAC-2 macrophages in the neointima at 28 days 
compared with PBS-treated rats (0.89 ± 0.084% vs. 1.66 
± 0.16%; P < 0.05, day 28) (Figures 7A and 7B, Table 
S2), and had enhanced levels of YM-1+ macrophages 
at 7days and 28 days (7.81 ± 0.47% vs 11.74 ± 0.75%; P 
< 0.01, day 7; 0.63 ± 0.12% vs. 1.32 ± 0.072%; P < 0.01, 
day 28) (Figures 7C and 7D, Table S2). Thus, the 
M2Es resulted in an altered inflammatory cell 
phenotype within the stented vessels. 
 
 
Figure 4. Exosomes mediate communication between M2 macrophages and VSMCs. (A) Isolated exosomes from M2 macrophages were examined by TEM. The scale bars 
indicate 100 nm. (B) TEM of p3-RASMCs treated with a 17 nm nanoparticle-labeled M2 macrophage exosome. The scale bars indicate 100 nm. (C) Size distributions of M2 
macrophages-derived exosomes were identified using the NTA. (D) VSMCs were incubated with DID-labeled M2 macrophages-derived exosomes (100 µg/mL) for 3, 6, 12 and 
24 h, and the exosome uptake by the VSMCs was detected (original magnification, ×630, scale bar: 25 µm; enlarged view, × 1890, scale bar: 10 µm). Arrows indicate the fusion 
of the membrane. (E) Confocal projection from 3D images of M2 macrophages exosome-internalized VSMCs after 12 h treatment with Imaris 7.2.3, scale bar: 25 µm. (F) Relative 
quantification of DID-dyed M2Es ingested into VSMCs, the fluorescence intensity of each group was normalized by the fluorescence intensity of M2 macrophages exosomes in 
VSMCs after 3 h (n = 6). **P < 0.01, **** P < 0.0001 versus the untreated group at the corresponding times and area, # P < 0.05 VAMCs treated with M2Es at 12 h versus the 
VAMCs treated with M2Es at 24 h; one-way, repeated-measures ANOVA. 
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Figure 5. Exosomes secreted by M2 macrophages reduced the stiffness of SMCs and promoted SMC dedifferentiation. (A) Representative force curves of force upon approach 
between the sphere and PRASMCs (light green-blue) and PRASMCs treated with M2Es (dark green-blue). (B) Quantification of resistance to mechanical deformation (stiffness) 
of cells as in A at an applied load of 30 nN. Error bars represent Mean ± SEM. P values indicate the statistical significance of differences of treatments versus the relevant control. 
*** P <0.001 by unpaired, two-tailed Student's t-test. (C) FITC-phalloidin dyeing of PRASMC. Treatment with 5 µg/mL FITC-phalloidin detects PRASMCs' F-actin after 24 h of 
M2Es stimulation. Scale bar: 10 µm. M2Es: Primary RASMC treated with M2 macrophages exosome. (D) Quiescent RASMCs were grown in media free FBS (NC) and co-cultured 
with M2 macrophages in a Transwell (M2T) or exposed to exosomes derived from M2 macrophages (M2Es) for 24 h before the expression of c-KIT and SM22α were determined 
by immunofluorescence, scale bar: 10 µm. (E) Representative immunoblots for SMC differentiation markers (SM22α and α-SMA) and stem cell marker (c-KIT) in lysates from 
quiescent cells grown in FBS- free SMCM for 24 h. (F) The levels of c-KIT, SM22α and α-SMA were determined using specific antisera against these antigens. Images are 
representative of blots with similar results. Equal loading was confirmed by Ponceau S staining of the membranes and by measuring the constitutive GAPDH gene. The results are 
representative of three independent experiments. Error bars are Mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 versus the control group by one-way, repeated-measures 
ANOVA, ##P < 0.01, ###P < 0.001 versus the M2T-treated group at the corresponding times; one-way, repeated-measures ANOVA. (G) Quantification of relative mRNA 
expression of SM22α, α-SMA and c-Kit in the NC, M2T and M2Es. Error bars are Mean ± SEM. ***P < 0.001 vs. corresponding NC (one-way, repeated-measures ANOVA). 
 
The neointimal lesions from the M2Es-treated 
rats contained significantly more c-KIT and SM22α 
double-positive cells at 7 and 28 days (Figures 8A-C, 
Table S2). Additionally, the M2Es-treated rats 
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contained greater numbers of c-KIT+ with SM22αlow 
the SMCs in neointima compared with PBS-treated 
rats at 7 and 28 days (38.22 ± 1.67% vs 17.94 ± 0.81%, P 
< 0.001, day 7; 69.16 ± 3.51% vs 58.32 ± 2.56%, P < 0.05, 
day 28) (Figure 8D). No difference in cell 
dedifferentiation was observed after quantification of 
the cells in the media (Figure S10, Table S2). M2Es 
can accelerate the dedifferentiation of VSMCs after 
stent implantation. Immunohistochemistry showed 
that more PCNA+ cells were found in the neointima of 
the M2Es-treated group compared with that of the 
PBS-treated group (1.28 ± 0.22% vs 4.06 ± 0.79%, 7 
days; 1.96 ± 0.34% vs 5.24 ± 0.55%, 28 days) (Figures 
S11A and S11B, Table S2). 
Increased AP-1 mediates the dedifferentiation 
of the RASMCs that absorbed M2Es 
We compared the gene expression profile of 
RASMCs and RASMCs co-cultured with M2 
macrophages by RNA-seq to further characterize 
RASMCs co-cultured with M2 macrophages. The top 
10 functional pathways of significance (p-value) in the 
KEGG enrichment analysis results were visualized by 
line and bar graphs. Pathways relevant to this study 
were the MAPK signaling pathway, endocytosis, focal 
adhesion, cellular senescence, fluid shear stress and 
atherosclerosis and autophagy-animal (Figure S12). 
Based on these findings, we speculated that the 
MAPK pathway plays an important role in the 
 
 
Figure 6. Morphometric analysis of stented abdominal aortas of rats with PBS treatment and M2Es treatment 7 and 28 days after stent placement. (A) neointimal area, (B) 
neointimal/media (N/M) ratio, (C) luminal area, and (D) percent stenosis. N = 7 for each group. *P <0.05, **P <0.01 versus PBS-treated groups (one-way, repeated-measures ANOVA). 
(E) Representative H&E stained sections from PBS-treated groups and M2Es-treated groups are seen 7 days and 28 days post-stenting. Scale bar: 200 µm. 
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process of VSMC dedifferentiation. Genes up-
regulated in RASMCs co-cultured with M2 
macrophages were associated with known stem cell 
signatures (Kitlg, Cd44, Sox17, Klf4, Nkx-5, Flt1, and 
Rexo1) (Figure 9A). On the other hand, genes 
associated with the SMC signature were 
downregulated in RASMCs co-cultured with M2 
macrophages (Figure 9A). Although our RNA-seq did 
not detect that the c-Kit level changed in RASMCs 
co-cultured with M2 macrophages, qRT-PCR did find 
that c-Kit was also increased in M2Es-treated 
RASMCs (Figure 9B). 
Importantly, bioinformatics analysis revealed 
that the expression of MAPK/AP-1 pathway genes 
(Sos1, Sos2, Rras2, Kras, Nras, Rras, Braf, Map2k1, 
Rps6ka1, Rps6ka2, Fos, and Fosl1) was significantly 
increased in RASMCs co-cultured with M2 
macrophages, indicating AP-1 activity was increased 
in RASMCs co-cultured with M2 macrophages. 
Increased AP-1 activity in the RASMCs co-cultured 
with M2 macrophages might be responsible for the 
dedifferentiation of RASMCs induced by M2Es. 
qRT-PCR confirmed that Fosl1 and other AP-1 
dependent genes were highly expressed in the 
RASMCs that absorbed M2Es (Figure 9B). 
M2Es-treated rats highly expressed AP-1 in the 
neointima compared with PBS-treated rats at 7 and 28 
days (1.76 ± 0.46% vs 6.72 ± 0.32%, P < 0.001, 7 days; 
3.41 ± 0.37% vs 7.91 ± 0.34%, P < 0.001, 28 days) 
(Figure 9C). 
Next, we used T-5224, a specific inhibitor of 
AP-1, to investigate whether AP-1 plays a functional 
role in the process of VSMC dedifferentiation. 
qRT-PCR confirmed that T-5224 potently inhibited 
AP-1 activity in M2Es-treated RASMCs (Figure 9D). 
MAPK/AP-1 pathway genes and stem cell signature 
related genes were downregulated, and SMC 
signature related genes were upregulated in RASMCs 
24 h after culture in the presence of M2Es and T-5224 
(10 µM) (Figure 9D). Immunofluorescence 
examination revealed that the expression of c-KIT in 
RASMCs stimulated by M2Es was significantly 
downregulated after AP-1 inhibition (Figure 9E). At 
the same time, the change of F-actin caused by M2Es 
also resumed after AP-1 was inhibited (Figure 9F). 
Moreover, T-5224 also significantly inhibited M2Es- 
induced RASMC proliferation (51.35 ± 2.09% vs 36.59 
± 4.28%, P < 0.05) (Figures 9G and 9H). In addition, 
the inhibition of AP-1 had no effect on the expression 
of caspase-3 in RASMCs (Figure S14). 
Discussion 
The aim of this study was to investigate the roles 
of M2 macrophage-derived exosomes on VSMC 
dedifferentiation and stem cell acquisition, including 
the underlying mechanism after stent implantation. 
We made the unexpected observation that VSMCs 
strongly express c-KIT under the stimulation of 
exosomes secreted by M2 macrophages. Our findings 
also revealed that cell-to-cell communication between 
VSMCs and macrophages by M2 macrophage-derived 
exosomes (which increases the number of VSMCs 
with a c-KIT+ stem cell phenotype) may play a major 
role in early neointimal formation after stent 
implantation. 
 
 
Figure 7. Inflammatory cells in neointimal lesions of M2Es-treated stented rats. (A) Representative images and (B) quantification of MAC-2 staining (% neointimal area) are seen 
in sections of stented vessels from PBS-treated and M2Es-treated rats at 7 and 28 days post-stenting (scale bar: 50 µm). (C) Representative images and (D) quantification of YM-1 
staining (% neointimal area) are seen in sections of stented vessels from PBS-treated and M2Es-treated rats at 7 and 28 days post-stenting. Scale bar: 100 µm. *P <0.05; **P <0.01 
versus PBS-treated rats (one-way, repeated-measures ANOVA). 
Theranostics 2020, Vol. 10, Issue 23 
 
 
http://www.thno.org 
10724 
 
Figure 8. M2Es promote VSMC dedifferentiation in a rat abdominal aortic stent implantation model. (A) Immunofluorescence staining of paraffin sections at the site of the 
stented vessels. Scale bar: 25 µm. (B) The number of c-KIT+ cells was counted in the neointima. (C) The number of SM22α+ cells was counted in the neointima. (D) Percentage 
of c-KIT and SM22α double-positive cells was determined in the neointima at 7 and 28 days’ post-stent placement. N = 7 for each group. *P <0.05, **P <0.01, ***P <0.001 versus 
the PBS-treated group at the corresponding times and for the same region (one way, repeated-measures ANOVA). Abbreviations: S, Stent; L, Lumen; M, Media; N, Neointima. 
 
M2 macrophages are involved in the neointima 
after stent implantation 
Macrophage infiltration is quick and inevitable 
in the progression of neointimal formation. Previous 
in vivo studies suggested that macrophage infiltration 
is important in early thrombotic formation, VSMC 
migration, proliferation and apoptosis, and 
extracellular matrix production [19,20]. Both M1 and 
M2 macrophages are found in the neointima after 
coronary stent implantation [21]. It has been proposed 
that MCP-1-recruited macrophages induce intra 
aneurysmal tissue healing [22]. Additionally, the 
scaffold could diminish the inflammatory reaction by 
reducing Tumor Necrosis Factor-α (TNF-α) secretion, 
upregulating the expression of M2 related genes, and 
increasing the number of M2 macrophages within the 
scaffold [23]. Other findings support the hypothesis 
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that additional M2 macrophages might cause less 
in-stent restenosis [21]. Our discovery proves for the 
first time that CD23+ M2 macrophages infiltrated into 
the neointima and around the stent filaments. This 
result is consistent with a previous report that M2 
macrophages mainly localize in the neointima in a 
gene knock-out mouse stent implantation model 
[21,24]. Since M2 macrophages promote repair, it has 
been proposed that increasing M2 macrophage 
numbers in the wound may accelerate wound healing 
[25,26]. Prostaglandin E2 hydrogel improves 
cutaneous wound healing via M2 macrophages 
polarization [27]. Hence, M2 macrophages play an 
important role in vascular wound healing. 
 
 
Figure 9. Activation of AP-1 in RASMCs facilitated VSMC dedifferentiation. (A) Heatmap displaying genes that were differentially expressed between RASMCs and RASMCs 
co-cultured with M2 macrophages. (B) qRT-PCR showing the expression of AP-1 target genes in RASMCs and M2Es-treated RASMCs. Data represent Mean ± SEM.*P < 0.05, **P 
< 0.01, ***P < 0.001 (Student's t-test). (C) Representative images and quantification of AP-1 staining (% neointimal area) are seen in sections of stented vessels from PBS-treated 
and M2Es-treated rats at 7 days and 28 days post-stenting (scale bar: 50 µm). Data represent Mean ± SEM. ***P < 0.001 (one way, repeated-measures ANOVA). (D) qRT-PCR 
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verified the dedifferentiation and AP-1 pathways of M2Es-treated RASMC after AP-1 inhibition. Data represent Mean ± SEM.*P < 0.05, **P < 0.01, ***P < 0.001 (one-way, 
repeated-measures ANOVA). (E) Co-immunostaining for SM22α (green) and c-KIT (red) in RASMCs 24 h after culture in the presence of M2Es and/or T-5224 (10 µM). Nuclei 
were stained with DAPI (blue). Scale bar: 10 µm. *P < 0.05, **P < 0.01, ***P < 0.001 (one way, repeated-measures ANOVA). (F) FITC-phalloidin dyeing of RASMCs. Treatment 
with 5 µg/mL FITC-phalloidin detects RASMCs' F-actin 24 h after culture in the presence of M2Es and/or T-5224 (10 µM). Scale bar: 100 µm. Enlarged view scale bar: 10 µm. (G) 
Representative images of RASMCs labeled with Ki-67 (red) 24 h after different treatments. Scale bar = 100 µm. (H) Quantification of the percentages of Ki-67+ cells in RASMCs 
24 h after different treatments. Values are Mean ± SEM (n = 6). *P < 0.05 by one-way, repeated-measures ANOVA. 
 
Macrophage exosomes are essential for VSMC 
fate regulation 
Exosomes secreted by M2 macrophages induce 
VSMC softening and dedifferentiation. An indirect 
co-culture system is suitable for simulating the 
cell-cell crosstalk, which could better simulate the 
early cellular behavior after stent implantation in vivo. 
Macrophage-derived exosomes can easily reach 
inflammatory sites and even cross the blood-brain 
barrier [28]. Macrophage-derived foam cell released 
EVs were capable of transporting proteins to VSMCs, 
thus activating the ERK and Akt pathways in VSMCs 
and promoting VSMC migration and adhesion [29]. 
Resistin-treated macrophage supernatant culture 
medium under different stimulations induces a shift 
from proliferation to apoptosis in VSMCs [30]. 
Considering the pore size of Transwells and the 
diameter of the DII-stained membrane, we speculate 
that EVs secreted by macrophages may promote 
VSMC softening and dedifferentiation. In some 
special disease models, treatment of primary human 
pulmonary arterial smooth muscle cells with these 
EVs resulted in a significant increase in smooth 
muscle proliferation [31]. However, they did not 
detect cell fate. In vitro Co-Cr alloy stent co-cultured 
systems, macrophages accelerate the proliferation of 
VSMCs by recruiting more macrophages [32]. The 
phenotypes indicate the VSMCs underwent 
dedifferentiation with a change in function. 
VSMCs that engulfed exosomes participate in 
vascular therapy 
VSMCs are a major neointimal constituent after 
stenting/vascular injury. In terms of the malignant 
proliferation of VSMCs caused by obesity, some 
studies showed that perivascular adipose tissue- 
derived extracellular vesicles enhanced VSMC 
proliferation and migration [33]. At the same time, 
mesenchymal stem cells (MSCs) derived exosomes 
suppressed VSMC proliferation and migration and 
established neointimal formation in rat carotid 
arteries following angioplasty [29]. In this paper, we 
showed that VSMCs rapidly cover the area of intimal 
injury and stent filaments and block contact with the 
blood at day 7 after stenting. A small subpopulation 
of resident VSMCs with a stem cell phenotype may be 
stimulated to proliferate and accumulate into the 
tunica intima in response to chronic injury or 
atherosclerotic pathogeny [34-36]. 
Rare c-KIT+ cells are observed in the 
sub-endothelial and outer portion of adult rat aortic 
media. Our results show that c-KIT expression was 
upregulated in VSMCs after stent implantation. 
Studies in rodent models indicated that the expression 
of c-KIT might protect VSMCs against apoptosis and 
maintain intimal hyperplasia after vascular injury 
[37]. Previous studies have shown that stem cell 
differentiation or iPS formation was accompanied by 
changes in cell stiffness [10,19,38]. In this study, we 
found that the VSMCs' stiffness was significantly 
decreased under the stimulation of macrophages. 
Therefore, stem cell factor (SCF)/c-KIT signaling may 
play a role in VSMC pathophysiology during the 
development of intimal hyperplasia [39]. 
The novel and most interesting finding of the 
present study is that co-culture of VSMCs with M2Es 
resulted in the dedifferentiation of VSMCs. This 
suggests that M2Es induce an increase of VSMCs with 
a c-KIT+ stem cell phenotype to induce repair in 
injured blood vessels. Exogenous M2Es can increase 
the stemness of VSMCs after vascular injury in a short 
time and strengthen their vascular healing potency. 
Exosome-based therapy in cancer and organ 
abnormality and mesenchymal stem cell 
transplantation have received increasing attention in 
recent years [40,41]. We provide evidence that 
exogenous M2Es induce vascular repair through 
VSMC expressing c-KIT. It is possible that c-KIT 
suppresses nuclear factor kappa-B (NF-κB)-regulated 
pathways in VSMCs to prevent their pro- 
inflammatory transformation [9,12]. 
AP-1, a transcription factor, participates in the 
regulation of proliferation, migration and cell cycle 
progression in VSMCs [42-44]. Additionally, the 
activation of AP-1 plays an important role in the 
process of aging [45], atherosclerosis [46,47], and 
vascular remodeling [48-50]. According to the latest 
research, AP-1 plays an essential role in the 
cardiomyocyte response to injury by regulating 
chromatin accessibility changes, thereby allowing the 
activation of gene expression programs that promote 
cardiomyocyte dedifferentiation, proliferation, and 
protrusion into the injured area [51]. In our study, the 
dedifferentiation of VSMCs after stent implantation 
was accompanied by the activation of AP-1. In vitro, 
when AP-1 was inhibited, the dedifferentiation of 
VSMCs induced by M2Es was also inhibited. 
In conclusion, this study revealed cell-cell 
communication between M2 macrophages and 
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VSMCs that promotes re-endothelialization after stent 
implantation. Thus, our study reveals a new 
mechanism of M2E-induced re-endothelialization: 
M2Es increase VSMC dedifferentiation via an M2 
macrophages → exosomes → MAPK (AP-1) pathway. 
The challenge for future studies will be to identify the 
component in the M2 macrophage exosomes that 
induces phenotypic transitions of VSMCs. 
Abbreviations 
VSMCs: vascular smooth muscle cells; A7R5: rat 
aortic smooth muscle cells; RASMC: rat aorta smooth 
muscle cells; THP-1: human leukemic monocyte; ETO: 
ethylene oxide; EVs: extracellular vesicle; PBS: 
phosphate buffer saline; M2E: exosomes derived from 
M2 macrophage; H&E: hematoxylin and eosin; RPMI: 
roswell park memorial institute; PMA: phorbol 
12-myristate 13-acetate; BSA: bovine serum albumin; 
LPS: lipopolysaccharide; IFN-γ: Interferon-gamma; 
IL-4: interleukin-4; IL-13: interleukin-13; DMEM: 
dulbecco's modified eagle's medium; FBS: fetal bovine 
serum; NTA: nanoparticle tracking analysis; PAGE: 
polyacrylamide gel electrophoresis; PVDF: polyvinyl-
idene fluoride; TBST: tris-buffered saline Tween-20; 
HRP: horseradish peroxidase; ECL: electrochemi-
luminescence; AFM: atomic force microscopy; TEM: 
transmission electron microscopy; FITC: fluorescein 
isothiocyanate; DII: 1,1′-dioctadecyl-3,3,3′,3′-tetra-
methylindocarbocyanine perchlorate; DIO: 3,3′- 
dioctadecyloxacarbocyanine perchlorate; DID: 1,1- 
dioctadecyl-3,3,3,3-tetramethylindodicarbocyanine; 
SMCM: smooth muscle cell medium; TNF-α: tumor 
necrosis factor-α; MCP-1: monocyte chemotactic 
protein-1; iPS: induced pluripotent stem cells; SCF: 
stem cell factor; NF-κB: nuclear factor kappa-B; 
PCNA: proliferating cell nuclear antigen; MAC-2: 
total galactose-specific lectin 3; YM-1: total chitinase 
3–like 3; AP-1: activator protein 1. 
Supplementary Material  
Supplementary figures and tables. 
http://www.thno.org/v10p10712s1.pdf  
Acknowledgments 
This study was partially supported by grants 
from the National Natural Science Foundation of 
China (31971242, 31701275) and Chongqing Science 
and Technology Bureau (cstc2019jcyj-zdxm0033), the 
National Key Technology R&D Program of China 
(2016YFC1102305), the Fundamental Research Funds 
for the Central Universities (2019CDXYSG0004). We 
are also thankful for the support from the Chongqing 
Engineering Laboratory in Vascular Implants and the 
Public Experiment Centre of State Bioindustrial Base 
(Chongqing) and the National “111 plan” (B06023). 
The authors would like to thank Professor Valerie 
Holt (Cambridge Virtual School) and Dr. Aron 
Rachamim (Senzo Health) for critically reviewing the 
manuscript. 
Author contributions 
WY performed the experiments, acquired, 
analyzed and interpreted the data, and drafted the 
manuscript. TL, TY, ZH and KQ performed the 
experiments, acquired, analyzed and interpreted the 
data. NW, CD and LD analyzed and interpreted the 
data, and edited the manuscript. GW, HG, JQ and WY 
conceived and designed the study, analyzed and 
interpreted the data, drafted and edited the 
manuscript. All authors approved the final version of 
the manuscript. 
Competing Interests 
The authors have declared that no competing 
interest exists. 
References 
1. Versaci F, Gaspardone A, Tomai F, Proietti I, Ghini AS, Altamura L, et al. A 
comparison of coronary artery stenting with angioplasty for isolated stenosis 
of the proximal left anterior descending coronary artery: five year clinical 
follow up. Heart. 2004; 90: 672-5. 
 2. Gasior P, Cheng Y, Valencia AF, McGregor J, Conditt GB, Kaluza GL, et al. 
Impact of Fluoropolymer-Based Paclitaxel Delivery on Neointimal 
Proliferation and Vascular Healing: A Comparative Peripheral Drug-Eluting 
Stent Study in the Familial Hypercholesterolemic Swine Model of Femoral 
Restenosis. Circ Cardiovasc Interv. 2017; 10: e4450. 
 3. Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation 
and endothelial regeneration after vascular injury and stenting: approach to 
therapy. Circ J. 2011; 75: 1287-96. 
 4. Niu C, Wang X, Zhao M, Cai T, Liu P, Li J, et al. Macrophage Foam 
Cell-Derived Extracellular Vesicles Promote Vascular Smooth Muscle Cell 
Migration and Adhesion. J Am Heart Assoc. 2016; 5: e4099. 
 5. Kawamoto R, Yamashita A, Nishihira K, Furukoji E, Hatakeyama K, Ishikawa 
T, et al. Different inflammatory response and oxidative stress in neointimal 
hyperplasia after balloon angioplasty and stent implantation in cholesterol-fed 
rabbits. Pathol Res Pract. 2006; 202: 447-56. 
 6. Klotz L, Norman S, Vieira JM, Masters M, Rohling M, Dube KN, et al. Cardiac 
lymphatics are heterogeneous in origin and respond to injury. Nature. 2015; 
522: 62-7. 
 7. Zhu J, Liu B, Wang Z, Wang D, Ni H, Zhang L, et al. Exosomes from 
nicotine-stimulated macrophages accelerate atherosclerosis through 
miR-21-3p/PTEN-mediated VSMC migration and proliferation. Theranostics. 
2019; 9: 6901-19. 
 8. Wang Z, Zhu H, Shi H, Zhao H, Gao R, Weng X, et al. Exosomes derived from 
M1 macrophages aggravate neointimal hyperplasia following carotid artery 
injuries in mice through miR-222/CDKN1B/CDKN1C pathway. Cell Death 
Dis. 2019; 10: 422. 
 9. Song L, Martinez L, Zigmond ZM, Hernandez DR, Lassance-Soares RM, 
Selman G, et al. c-Kit modifies the inflammatory status of smooth muscle cells. 
Peerj. 2017; 5: e3418. 
10. Bongiorno T, Chojnowski JL, Lauderdale JD, Sulchek T. Cellular Stiffness as a 
Novel Stemness Marker in the Corneal Limbus. Biophys J. 2016; 111: 1761-72. 
11. Le Bras A, Yu B, Issa BS, Hong X, Zhang Z, Hu Y, et al. Adventitial Sca1+ Cells 
Transduced with ETV2 Are Committed to the Endothelial Fate and Improve 
Vascular Remodeling After Injury. Arterioscler Thromb Vasc Biol. 2018; 38: 
232-44. 
12. Orlandi A, Di Lascio A, Francesconi A, Scioli MG, Arcuri G, Ferlosio A, et al. 
Stem cell marker expression and proliferation and apoptosis of vascular 
smooth muscle cells. Cell Cycle. 2008; 7: 3889-97. 
13. Oyamada S, Ma X, Wu T, Robich MP, Wu H, Wang X, et al. Trans-iliac rat aorta 
stenting: a novel high throughput preclinical stent model for restenosis and 
thrombosis. J Surg Res. 2011; 166: e91-5. 
14. Liu X, Cheng Y, Yang J, Xu L, Zhang C. Cell-specific effects of miR-221/222 in 
vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol. 
2012; 52: 245-55. 
15. Bradshaw SH, Kennedy L, Dexter DF, Veinot JP. A practical method to rapidly 
dissolve metallic stents. Cardiovasc Pathol. 2009; 18: 127-33. 
Theranostics 2020, Vol. 10, Issue 23 
 
 
http://www.thno.org 
10728 
16. Margariti A, Winkler B, Karamariti E, Zampetaki A, Tsai TN, Baban D, et al. 
Direct reprogramming of fibroblasts into endothelial cells capable of 
angiogenesis and reendothelialization in tissue-engineered vessels. Proc Natl 
Acad Sci U S A. 2012; 109: 13793-8. 
17. Pillarisetti A, Desai JP, Ladjal H, Schiffmacher A, Ferreira A, Keefer CL. 
Mechanical phenotyping of mouse embryonic stem cells: increase in stiffness 
with differentiation. Cell Reprogram. 2011; 13: 371-80. 
18. Andries LJ, Brutsaert DL, Sys SU. Nonuniformity of endothelial constitutive 
nitric oxide synthase distribution in cardiac endothelium. Circ Res. 1998; 82: 
195-203. 
19. Hehrlein C, Kaiser S, Riessen R, Metz J, Fritz P, Kubler W. External beam 
radiation after stent implantation increases neointimal hyperplasia by 
augmenting smooth muscle cell proliferation and extracellular matrix 
accumulation. J Am Coll Cardiol. 1999; 34: 561-6. 
20. Hlawaty H, Jacob MP, Louedec L, Letourneur D, Brink C, Michel JB, et al. 
Leukotriene receptor antagonism and the prevention of extracellular matrix 
degradation during atherosclerosis and in-stent stenosis. Arterioscler Thromb 
Vasc Biol. 2009; 29: 518-24. 
21. McDonald RA, Halliday CA, Miller AM, Diver LA, Dakin RS, Montgomery J, 
et al. Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in 
Vascular Remodeling and Inflammation. J Am Coll Cardiol. 2015; 65: 2314-27. 
22. Hoh BL, Hosaka K, Downes DP, Nowicki KW, Fernandez CE, Batich CD, et al. 
Monocyte chemotactic protein-1 promotes inflammatory vascular repair of 
murine carotid aneurysms via a macrophage inflammatory protein-1alpha 
and macrophage inflammatory protein-2-dependent pathway. Circulation. 
2011; 124: 2243-52. 
23. Wang Z, Wu Y, Wang J, Zhang C, Yan H, Zhu M, et al. Effect of Resveratrol on 
Modulation of Endothelial Cells and Macrophages for Rapid Vascular 
Regeneration from Electrospun Poly(epsilon-caprolactone) Scaffolds. ACS 
Appl Mater Interfaces. 2017; 9: 19541-51. 
24. Soda T, Suzuki H, Iso Y, Kusuyama T, Omori Y, Sato T, et al. Bone marrow 
cells contribute to neointimal formation after stent implantation in swine. Int J 
Cardiol. 2007; 121: 44-52. 
25. Hesketh M, Sahin KB, West ZE, Murray RZ. Macrophage Phenotypes Regulate 
Scar Formation and Chronic Wound Healing. Int J Mol Sci. 2017; 18: 1545-55. 
26. Das A, Sinha M, Datta S, Abas M, Chaffee S, Sen CK, et al. Monocyte and 
macrophage plasticity in tissue repair and regeneration. Am J Pathol. 2015; 
185: 2596-606. 
27. Zhang S, Liu Y, Zhang X, Zhu D, Qi X, Cao X, et al. Prostaglandin E2 hydrogel 
improves cutaneous wound healing via M2 macrophages polarization. 
Theranostics. 2018; 8: 5348-61. 
28. Yuan D, Zhao Y, Banks WA, Bullock KM, Haney M, Batrakova E, et al. 
Macrophage exosomes as natural nanocarriers for protein delivery to inflamed 
brain. Biomaterials. 2017; 142: 1-12. 
29. Wang D, Gao B, Yue J, Liu F, Liu Y, Fu W, et al. Exosomes from mesenchymal 
stem cells expressing miR-125b inhibit neointimal hyperplasia via myosin IE. J 
Cell Mol Med. 2019; 23: 1528-40. 
30. Zuniga MC, Raghuraman G, Zhou W. Physiologic levels of resistin induce a 
shift from proliferation to apoptosis in macrophage and VSMC co-culture. 
Surgery. 2018; 163: 906-11. 
31. Sharma H, Chinnappan M, Agarwal S, Dalvi P, Gunewardena S, 
O'Brien-Ladner A, et al. Macrophage-derived extracellular vesicles mediate 
smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV 
infection and substance abuse. Faseb J. 2018; 32: 5174-85. 
32. Anderson JA, Lamichhane S, Vierhout T, Engebretson D. Determining the 
cross-talk between smooth muscle cells and macrophages on a 
cobalt-chromium stent material surface using an in vitro postimplantation 
coculture model. J Biomed Mater Res a. 2018; 106: 673-85. 
33. Li X, Ballantyne LL, Yu Y, Funk CD. Perivascular adipose tissue-derived 
extracellular vesicle miR-221-3p mediates vascular remodeling. Faseb J. 2019; 
33: 12704-22. 
34. Bentzon JF, Weile C, Sondergaard CS, Hindkjaer J, Kassem M, Falk E. Smooth 
muscle cells in atherosclerosis originate from the local vessel wall and not 
circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc 
Biol. 2006; 26: 2696-702. 
35. Tsai TN, Kirton JP, Campagnolo P, Zhang L, Xiao Q, Zhang Z, et al. 
Contribution of stem cells to neointimal formation of decellularized vessel 
grafts in a novel mouse model. Am J Pathol. 2012; 181: 362-73. 
36. Zhang L, Issa BS, Chen T, Zhou B, Xu Q. Role of Resident Stem Cells in Vessel 
Formation and Arteriosclerosis. Circ Res. 2018; 122: 1608-24. 
37. Wang CH, Verma S, Hsieh IC, Hung A, Cheng TT, Wang SY, et al. Stem cell 
factor attenuates vascular smooth muscle apoptosis and increases intimal 
hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol. 2007; 27: 
540-7. 
38. Trajkovic K, Jeong H, Krainc D. Mutant Huntingtin Is Secreted via a Late 
Endosomal/Lysosomal Unconventional Secretory Pathway. J Neurosci. 2017; 
37: 9000-12. 
39. Hollenbeck ST, Sakakibara K, Faries PL, Workhu B, Liu B, Kent KC. Stem cell 
factor and c-kit are expressed by and may affect vascular SMCs through an 
autocrine pathway. J Surg Res. 2004; 120: 288-94. 
40. Phinney DG, Pittenger MF. Concise Review: MSC-Derived Exosomes for 
Cell-Free Therapy. Stem Cells. 2017; 35: 851-8. 
41. Matthay MA, Abman SH. Exosome-based Therapy for Bronchopulmonary 
Dysplasia. Am J Respir Crit Care Med. 2018; 197: 10-2. 
42. Lee J, Moon S, Hwang C, Nam K, Kim Y, Yoon H, et al. A novel function of 
benzyl isothiocyanate in vascular smooth muscle cells: The role of ERK1/2, 
cell cycle regulation, and matrix metalloproteinase-9. J Cell Physiol. 2005; 203: 
493-500. 
43. Li M, Liu R, Timblin CR, Meyer SG, Mossman BT, Fukagawa NK. Age affects 
ERK1/2 and NRF2 signaling in the regulation of GCLC expression. J Cell 
Physiol. 2006; 206: 518-25. 
44. Li Y, Yan L, Zhang W, Hu N, Chen W, Wang H, et al. MicroRNA-21 inhibits 
platelet-derived growth factor-induced human aortic vascular smooth muscle 
cell proliferation and migration through targeting activator protein-1. Am J 
Transl Res. 2014; 6: 507-16. 
45. Rivard A, Principe N, Andres V. Age-dependent increase in c-fos activity and 
cyclin A expression in vascular smooth muscle cells. A potential link between 
aging, smooth muscle cell proliferation and atherosclerosis. Cardiovasc Res. 
2000; 45: 1026-34. 
46. Gao F, Zhang J, Ni T, Lin N, Lin H, Luo H, et al. Herpud1 deficiency could 
reduce amyloid-β40 expression and thereby suppress homocysteine-induced 
atherosclerosis by blocking the JNK/AP1 pathway. J Physiol Biochem. 2020; 
76: 383–391. 
47. Kim TJ, Yun YP. Potent inhibition of serum-stimulated responses in vascular 
smooth muscle cell proliferation by 2-chloro-3-(4-hexylphenyl)-amino-1,4- 
naphthoquinone, a newly synthesized 1,4-naphthoquinone derivative. Biol 
Pharm Bull. 2007; 30: 121-7. 
48. Cheng G, Wei L, Xiurong W, Xiangzhen L, Shiguang Z, Songbin F. IL-17 
Stimulates Migration of Carotid Artery Vascular Smooth Muscle Cells in an 
MMP-9 Dependent Manner via p38 MAPK and ERK1/2-Dependent NF-κB 
and AP-1 Activation. Cell Mol Neurobiol. 2009; 29: 1161-8. 
49. Seo KW, Lee SJ, Ye BH, Kim YW, Bae SS, Kim CD. Mechanical stretch 
enhances the expression and activity of osteopontin and MMP-2 via the 
Akt1/AP-1 pathways in VSMC. J Mol Cell Cardiol. 2015; 85: 13-24. 
50. Lee SJ, Baek SE, Jang MA, Kim CD. Osteopontin plays a key role in vascular 
smooth muscle cell proliferation via EGFR-mediated activation of AP-1 and 
C/EBPβ pathways. Pharmacol Res. 2016; 108: 1-8. 
51. Beisaw A, Kuenne C, Guenther S, Dallmann J, Wu C, Bentsen M, et al. AP-1 
Contributes to Chromatin Accessibility to Promote Sarcomere Disassembly 
and Cardiomyocyte Protrusion During Zebrafish Heart Regeneration. Circ 
Res. 2020; 126: 1760-78. 
